Strategic Performance and Market Dynamics
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here.
Chewy outperformed the broader pet category by roughly 2x to 3x, driven by a recurring revenue base where Autoship sales grew 9.3% to represent 84.6% of total net sales.
Management observed that while the consumer backdrop remains pressured, the environment has broadly stabilized to trends seen exiting Q1, with no further deterioration noted.
Performance attribution was bolstered by triple-digit revenue growth in Chewy Vet Care and triple-digit unit growth in the fresh and frozen portfolio., alongside a seventh consecutive quarter of mid-double-digit growth in the equine and farm business.
The retail product mix continues to shift toward high-margin categories like health and pharmacy, which helped maintain gross margins despite pressure on discretionary spending and premiumization.
Operational discipline and AI-enabled productivity are structurally lowering the variable cost to serve, contributing to a 70 basis point year-over-year improvement in SG&A leverage.
Management emphasized that their growth momentum is not dependent on a broader market recovery, but rather on scaling strategic platforms and deepening wallet share within the existing ecosystem.
Outlook and Strategic Initiatives
Full-year guidance assumes the consumer environment remains consistent with current levels, intentionally excluding any assumptions of a meaningful macroeconomic recovery for the balance of the year.
Management plans to launch a redesigned Chewy Plus program shortly, evolving the value proposition to include integrated health benefits aimed at deepening customer engagement and ecosystem attachment.
AI initiatives are projected to generate low tens of millions in cost savings for fiscal 2026, scaling to approximately $50 million on an annualized basis in fiscal 2027.
Advertising and marketing spend will increase in the second half, weighted toward Q3, to build brand awareness ahead of the holiday season and position the company for a strong start to 2027.
The company expects to remain opportunistic with share repurchases, viewing current share price levels as undervalued relative to the long-term earnings power of the business.
Non-Recurring Items and Risk Factors
Q2 adjusted EBITDA benefited from approximately $15 million in timing-related and discrete items, including tariff refunds, rebate shifts, and gift card breakage that are not indicative of the underlying run rate.
The acquisition of Modern Animal for $400 million was completed during the quarter, which currently acts as a modest drag on adjusted EBITDA margin as integration progresses.
Fuel costs are expected to remain a mid-single-digit million dollar headwind through the remainder of the fiscal year.
Management flagged a sharper slowdown in treat sales compared to core food, reflecting a consumer shift toward prioritizing essential consumables over discretionary toppers and snacks.
